newsfilter
← Latest News
Business Wire·

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia

Taiho Pharmaceutical Co., Ltd. ("Taiho") and Arcus Biosciences, Inc. (NYSE:RCUS, "Arcus")) announced that Taiho exercised its option to develop and, if approved, commercialize casdatifan (International Nonproprietary